8-K/A

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Oct 30, 2020
Document Date
Oct 29, 2020
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
KemPharm
Issuer
KEMPHARM, INC